This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Out of public health concerns and given the current travel restrictions and lab closures worldwide because of COVID-19, the 27th International Symposium on Hepatitis C Virus and Related Viruses (HCV2020), scheduled to take place July 6 – 9, 2020 in Montreal, Canada has been postponed to July 6 - 9, 2021 and will now be delivered Virtually.



Thomas Wynn

VP and Discovery Head - Inflammation and Immunology

Dr. Thomas A.Wynn is the Vice President of Discovery in the Inflammation and Immunology Research Unit at Pfizer, Cambridge, MA.  Prior to joining Pfizer in July 2017, he was the Chief of the Immunopathogenesis Section at the National Institute of Allergy and Infectious Diseases, NIH in Bethesda, MD. He received his Ph.D. from the Department of Medical Microbiology and Immunology at the University of Wisconsin, in Madison, Wisconsin. He has published over 300 scholarly research papers, reviews, and book chapters in many prestigious journals including Nature, Science, Nature Medicine, and Immunity and has contributed substantially to our understanding of the role of cytokines and growth factors in the progression and resolution of inflammation and fibrosis.  His research has also focused the role of macrophages, fibroblasts and tissue progenitor/stem cells in tissue repair and regeneration.  He serves as an advisory editor for the Journal of Experimental Medicine and as a consulting editor for the Journal of Clinical Investigation.  For the past five years, Thomson Reuters/Clarivate Analytics has included him among their list of "Highly Cited Researchers" in the field of Immunology.